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Background: Neurofibroma is a rare benign tumor. The isolated presence of such lesions in the preperitoneal space
with no evidence of systemic disease has never been reported in the literature.
Case presentation: A 29-year-old white man presented with a 12 months history of progressive abdominal distension.
Clinical examination revealed a bulky hypogastric mass. Abdominal computed tomography and pelvic magnetic
resonance imaging showed a large, well defined preperitoneal tumor measuring 18 x 17cm extending in the pelvis. A
computed tomography guided biopsy was performed which revealed a neurofibroma. Exploratory laparotomy showed
a well encapsulated elastic soft tumor in the preperitoneal space which measured 17 x 18cm and weighted 2 Kg. The
tumor was completely excised. No recurrence occurred after one year of follow-up.
Conclusion: Solitary preperitoneal neurofibroma is an extremely rare benign tumor. Its clinical and radiological signs
are nonspecific. Preoperative histology can be useful to guide the surgical approach which is the only curative
treatment.
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Neurofibroma is an uncommon benign tumor arising
from the peripheral nerve sheaths. The isolated presence
of neurofibromatous lesions in the preperitoneal space
(between the parietal peritoneum and transversalis
fascia), without any other sign of von Recklinghausen’s
disease has rarely been reported [1]. Authors report an
unusual case with a review of literature.
Case presentation
A 29-year-old white man, with no history of neuro-
fibromatosis or other systemic disease, was complaining
of insidious and progressive abdominal distension which
appeared 12 months prior to admission. He had hypo-
gastric abdominal pain and pollakiuries in the preceding
five months. There were no vomiting or transit disor-
ders, and no neurological symptoms.
On clinical examination, the patient was in good gen-
eral condition with a normal temperature, a body mass
index of 24 and no café au-lait spots or dermal neuro-
fibromas on his body. The palpation of the abdomen re-
vealed a well-defined, fixed and painless hypogastric* Correspondence: njouminoureddine@gmail.com
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unless otherwise stated.mass, 20 cm in diameter. Digital rectal examination was
normal.
All the standard hematological and serum biochemical
data were normal.
An abdomino-pelvic computed tomography (CT) scan
(Figure 1) revealed a massive, inhomogeneous, hypodense,
preperitoneal tumor, measuring 17 × 18cm extending in
the pelvis, crushing both ureters and compressing the
bladder. This mass was moderately enhanced with con-
trast. There were no signs of pelvic invasion or intra-
peritoneal effusion. Both kidneys were increased in size
with dilation of renal cavities but the renal cortex was
preserved.
Pelvic magnetic resonance imaging (Figure 2) revealed
a large, well encapsulated preperitoneal tumor, slightly
compressing the bladder and the pelvic ureters without
invasion of the adjacent structures and without pelvic
bone localization.
A CT-guided biopsy was performed revealing a conjunc-
tive tissue separated by a fuso-cellular proliferation com-
pound of Schwann cells with regular nuclei immersed in a
richly vascularized and myxoid fibrillar background. There
was no evidence of malignancy within the tissue obtained.
Immunohistochemically, the tumor cells were strongly. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Abdomino-pelvic computed tomography showed a
massive, inhomogeneous, hypodense abdominal tumor.
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ing a neurofibroma.
Surgical resection was decided by the multidisciplinary
meeting for cancer care. Exploratory laparotomy re-
vealed a well encapsulated elastic soft tumor in the pre-
peritoneal space. Upon incision of the linea alba, there
was a protrusion of the mass. It was easily cleaved before
the opening of the anterior parietal peritoneum. At the
end of excision, there was a peritoneal break due to size
of the mass (Figure 3).Figure 2 Pelvic magnetic resonance imaging showing a large,
well encapsulated preperitoneal tumor.The tumor measured 17 × 18 cm and weighted 2 Kg
(Figure 4). It was completely excised without macro-
scopic capsule breaking. No lymph nodes or other palp-
able intra-abdominal masses were discovered.
The histological and immuno-histochemical analysis
of the surgical specimen confirmed the preoperative
diagnosis (Figure 5). Thus, the tumor was diagnosed as a
solitary neurofibroma. The post-operative course was
uneventful. No adjuvant treatment was indicated. The
patient remains well without any sign of tumor recur-
rence on a CT scan performed 12 months after surgery.
Comments
Neurofibroma is a tumor of neural origin derived from
the cells that constitute the nerve sheath. It’s an uncom-
mon benign tumor found as a solitary tumor or as a par-
tial manifestation of neurofibromatosis type I (NF1, also
called von Recklinghausen’s disease) [2]. The cause of
solitary neurofibroma is still unknown [3], it is defined
by Marocchio et al. [4] as a hyperplastic hamartomatous
malformation rather than neoplastic. NF1 is an autosomal
dominant genetic syndrome caused by mutations in genes
coding for neurofibromin [5], it is characterized by cutane-
ous manifestations as cafe-au-lait spots with a large num-
ber of nervous system tumors [6]. The hereditary factorsFigure 3 Intraoperative view showing the well encapsulated
elastic soft tumor in the preperitoneal space.
Figure 4 Macroscopic appearance of the preperitoneal
neurofibroma; size = 17x18cm, weight = 2 kg.
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neurofibromas are absent in the solitary type [7].
This kind of neoplasms is known to mainly affect the
cutaneous nerves of the trunk, neck, and head [8,9].
Rare cases in the deep organs or in the peritoneal cavity
were also reported [10]. Concerning the retroperitoneal
location, exceptional cases of benign nerve sheaths tu-
mors were reported in large series of primitive retroperi-
toneal tumors [11,12]. To our knowledge, the presence
of solitary neurofibroma in the preperitoneal space has
never been reported in the literature.
Neurofibroma appears to affect adolescents and young
adults without a gender preference. It grows along the
peripheral nerves as a non-encapsulated focal mass with
well-defined margins [8,9].
The clinical manifestations of solitary neurofibromas
are not specific and change according to their locations,
their effect on gastrointestinal motility and their possibleFigure 5 Benign tumor cells immersed in a myxoid collagen
background (A) with elongated and wavy nuclei (B).impingement on contiguous structures, resulting in palp-
able masses, abdominal pain, and transit disorders due to
extra-luminal pressure [13-15]. The deep seated neuro-
fibroma on peripheral nerves and spinal roots frequently
leads to neurological disability [16].
Intra pelvic tumors are often diagnosed at a late stage
which is source of surgical resection difficulties [17].
Preoperative imaging is usually insufficient to establish
the diagnosis with certainty, only the histology can do.
In fact, the preoperative histological evidence can influ-
ence the treatment modifying the surgical approach,
conservative versus aggressive [10].
Surgical removal is the only treatment option. Unlike
our case, neurofibromas are difficult to manage surgi-
cally as they are extensively infiltrative and highly vascu-
lar [15,18].
Some authors posit that surgical resection is indicated
only when the tumor causes pain, neurological deficiencies
or when there is a strong suspicion of malignancy [19].
Solitary neurofibromas have a good prognosis, with
rare instances of haemorrhage, malignant changes and
local recurrences after excision [18,20].
Conclusion
The solitary preperitoneal neurofibroma is an extremely
rare benign tumor arising from nerve sheaths. Its clinical
and radiological signs are not specific. Preoperative
histological diagnosis can be useful to help choosing the
surgical approach, which is the gold-standard treatment
option. Unlike other sites, tumor excision in the preperi-
toneal location remains without difficulties.
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